Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

Semaglutide is marketed under the brand names, such as Ozempic, which is primarily prescribed for those with Type 2 diabetes, and Wegovy, which is commonly prescribed for weight loss. The drug mimics ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their prescribed obesity medication, according to findings published in Obesity.

Semaglutide v. tirzepatide: What to know about popular weight loss and diabetes drugs like Ozempic. By Evan MacDonald, Staff writer April 27, 2024.

Explore how to optimize your diet while on weight loss drugs like semaglutide and tirzepatide. Learn about the best foods to eat, those to avoid, and the importance of hydration and macronutrients.

Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity medications with no significantly higher risk for adverse events, according to findings from a network meta ...

Source Reference: Rodriguez PJ, et al "Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity" JAMA Intern Med 2024; DOI: 10.1001/jamainternmed.2024.2525.